OPKO Health, Inc.
OPK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $152 | $157 | $150 | $184 |
| % Growth | -3.3% | 4.6% | -18.3% | – |
| Cost of Goods Sold | $80 | $107 | $107 | $99 |
| Gross Profit | $71 | $49 | $43 | $85 |
| % Margin | 47% | 31.5% | 28.4% | 46.1% |
| R&D Expenses | $30 | $30 | $31 | $30 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $54 | $60 | $59 | $67 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$61 | $19 | $20 | $20 |
| Operating Expenses | $23 | $109 | $110 | $118 |
| Operating Income | $48 | -$60 | -$67 | -$33 |
| % Margin | 31.7% | -38.3% | -44.8% | -18% |
| Other Income/Exp. Net | -$7 | -$103 | -$6 | $68 |
| Pre-Tax Income | $41 | -$163 | -$73 | $35 |
| Tax Expense | -$20 | -$14 | -$6 | $21 |
| Net Income | $61 | -$148 | -$68 | $14 |
| % Margin | 40.4% | -94.7% | -45.1% | 7.6% |
| EPS | 0.03 | -0.22 | -0.1 | 0.02 |
| % Growth | 113.6% | -120% | -595% | – |
| EPS Diluted | 0.03 | -0.22 | -0.1 | 0.02 |
| Weighted Avg Shares Out | 777 | 672 | 672 | 797 |
| Weighted Avg Shares Out Dil | 780 | 672 | 672 | 694 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $3 | $5 | $4 |
| Interest Expense | $11 | $70 | $15 | $14 |
| Depreciation & Amortization | $23 | $23 | $23 | $24 |
| EBITDA | $76 | -$69 | -$34 | $73 |
| % Margin | 49.8% | -44.1% | -23% | 39.8% |